clofibric acid has been researched along with glyburide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alaniz-Palacios, A; Ávila-Villarreal, G; Estrada-Soto, S; González-Acevedo, C; Guerrero-Álvarez, J; Hidalgo-Figueroa, S; López-Vallejo, F; Medina-Franco, JL; Navarrete-Vázquez, G; Tlahuext, H; Webster, SP | 1 |
| Holler, HD; Janka, HU; Mehnert, H; Standl, A | 1 |
1 trial(s) available for clofibric acid and glyburide
| Article | Year |
|---|---|
[Carbohydrate metabolism in bezafibrate therapy. Controlled study of glibenclamide-treated diabetics with hyperlipidemia].
Topics: Aged; Bezafibrate; Carbohydrate Metabolism; Clinical Trials as Topic; Clofibrate; Clofibric Acid; Diabetes Complications; Diabetes Mellitus; Glyburide; Humans; Hyperlipidemias; Hypolipidemic Agents; Middle Aged; Patient Compliance | 1982 |
1 other study(ies) available for clofibric acid and glyburide
| Article | Year |
|---|---|
Discovery, synthesis and in combo studies of a tetrazole analogue of clofibric acid as a potent hypoglycemic agent.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Animals; Binding Sites; Blood Glucose; Catalytic Domain; Clofibric Acid; Crystallography, X-Ray; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Humans; Hydrogen Bonding; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Rats; Structure-Activity Relationship; Tetrazoles | 2013 |